178 related articles for article (PubMed ID: 35917895)
1. VCAM-1-binding peptide targeted cationic liposomes containing NLRP3 siRNA to modulate LDL transcytosis as a novel therapy for experimental atherosclerosis.
Jia X; Bai X; Yang X; Wang L; Lu Y; Zhu L; Zhao Y; Cheng W; Shu M; Mei Q; Jin S
Metabolism; 2022 Oct; 135():155274. PubMed ID: 35917895
[TBL] [Abstract][Full Text] [Related]
2. Serum amyloid A and interleukin -1β facilitate LDL transcytosis across endothelial cells and atherosclerosis via NF-κB/caveolin-1/cavin-1 pathway.
Jia X; Liu Z; Wang Y; Li G; Bai X
Atherosclerosis; 2023 Jun; 375():87-97. PubMed ID: 36935311
[TBL] [Abstract][Full Text] [Related]
3. GP73 enhances the ox-LDL-induced inflammatory response in THP-1 derived macrophages via affecting NLRP3 inflammasome signaling.
Lin YF; Li MH; Huang RH; Zhang SZ; Xu XF; Zhou HM; Liu MH; Liao XX; Liao LZ; Guo Y; Zhuang XD
Int J Cardiol; 2023 Sep; 387():131109. PubMed ID: 37271284
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-155 promotes the ox-LDL-induced activation of NLRP3 inflammasomes via the ERK1/2 pathway in THP-1 macrophages and aggravates atherosclerosis in ApoE-/- mice.
Yin R; Zhu X; Wang J; Yang S; Ma A; Xiao Q; Song J; Pan X
Ann Palliat Med; 2019 Nov; 8(5):676-689. PubMed ID: 31865729
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-30c-5p inhibits NLRP3 inflammasome-mediated endothelial cell pyroptosis through FOXO3 down-regulation in atherosclerosis.
Li P; Zhong X; Li J; Liu H; Ma X; He R; Zhao Y
Biochem Biophys Res Commun; 2018 Sep; 503(4):2833-2840. PubMed ID: 30119891
[TBL] [Abstract][Full Text] [Related]
6. Activation of NLRP3 inflammasomes contributes to hyperhomocysteinemia-aggravated inflammation and atherosclerosis in apoE-deficient mice.
Wang R; Wang Y; Mu N; Lou X; Li W; Chen Y; Fan D; Tan H
Lab Invest; 2017 Aug; 97(8):922-934. PubMed ID: 28394319
[TBL] [Abstract][Full Text] [Related]
7. P2X7R is involved in the progression of atherosclerosis by promoting NLRP3 inflammasome activation.
Peng K; Liu L; Wei D; Lv Y; Wang G; Xiong W; Wang X; Altaf A; Wang L; He D; Wang H; Qu P
Int J Mol Med; 2015 May; 35(5):1179-88. PubMed ID: 25761252
[TBL] [Abstract][Full Text] [Related]
8. NLRP3 Inflammasome Inhibition by MCC950 Reduces Atherosclerotic Lesion Development in Apolipoprotein E-Deficient Mice-Brief Report.
van der Heijden T; Kritikou E; Venema W; van Duijn J; van Santbrink PJ; Slütter B; Foks AC; Bot I; Kuiper J
Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1457-1461. PubMed ID: 28596375
[TBL] [Abstract][Full Text] [Related]
9. NFAT5 mediates hypertonic stress-induced atherosclerosis via activating NLRP3 inflammasome in endothelium.
Ma P; Zha S; Shen X; Zhao Y; Li L; Yang L; Lei M; Liu W
Cell Commun Signal; 2019 Aug; 17(1):102. PubMed ID: 31429763
[TBL] [Abstract][Full Text] [Related]
10. Deficient Chaperone-Mediated Autophagy Promotes Inflammation and Atherosclerosis.
Qiao L; Ma J; Zhang Z; Sui W; Zhai C; Xu D; Wang Z; Lu H; Zhang M; Zhang C; Chen W; Zhang Y
Circ Res; 2021 Dec; 129(12):1141-1157. PubMed ID: 34704457
[TBL] [Abstract][Full Text] [Related]
11. miR-155 activates the NLRP3 inflammasome by regulating the MEK/ERK/NF-κB pathway in carotid atherosclerotic plaques in ApoE
Peng Q; Yin R; Zhu X; Jin L; Wang J; Pan X; Ma A
J Physiol Biochem; 2022 May; 78(2):365-375. PubMed ID: 35079982
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-223-3p inhibits oxidized low-density lipoprotein-mediated NLRP3 inflammasome activation via directly targeting NLRP3 and FOXO3.
Xu W; Qian L; Yuan X; Lu Y
Clin Hemorheol Microcirc; 2022; 81(3):241-253. PubMed ID: 35275525
[TBL] [Abstract][Full Text] [Related]
13. NLRP3 Inflammasome Activation Controls Vascular Smooth Muscle Cells Phenotypic Switch in Atherosclerosis.
Burger F; Baptista D; Roth A; da Silva RF; Montecucco F; Mach F; Brandt KJ; Miteva K
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008765
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-181a regulates the activation of the NLRP3 inflammatory pathway by targeting MEK1 in THP-1 macrophages stimulated by ox-LDL.
Song J; Yang S; Yin R; Xiao Q; Ma A; Pan X
J Cell Biochem; 2019 Aug; 120(8):13640-13650. PubMed ID: 30938884
[TBL] [Abstract][Full Text] [Related]
15. Baicalin ameliorates atherosclerosis by inhibiting NLRP3 inflammasome in apolipoprotein E-deficient mice.
Zhao J; Wang Z; Yuan Z; Lv S; Su Q
Diab Vasc Dis Res; 2020; 17(6):1479164120977441. PubMed ID: 33269624
[TBL] [Abstract][Full Text] [Related]
16. Nur77 Deficiency Exacerbates Macrophage NLRP3 Inflammasome-Mediated Inflammation and Accelerates Atherosclerosis.
Yuan R; Zhang W; Nie P; Lan K; Yang X; Yin A; Xiao Q; Shen Y; Xu K; Wang X; Pan X; Shen L; He B
Oxid Med Cell Longev; 2022; 2022():2017815. PubMed ID: 35464766
[TBL] [Abstract][Full Text] [Related]
17. C1q/TNF-related protein-9 attenuates atherosclerosis through AMPK-NLRP3 inflammasome singling pathway.
Zhang H; Gong X; Ni S; Wang Y; Zhu L; Ji N
Int Immunopharmacol; 2019 Dec; 77():105934. PubMed ID: 31727560
[TBL] [Abstract][Full Text] [Related]
18. CRP-Induced NLRP3 Inflammasome Activation Increases LDL Transcytosis Across Endothelial Cells.
Bian F; Yang XY; Xu G; Zheng T; Jin S
Front Pharmacol; 2019; 10():40. PubMed ID: 30761006
[TBL] [Abstract][Full Text] [Related]
19. Fucoidan Inhibits NLRP3 Inflammasome Activation by Enhancing p62/SQSTM1-Dependent Selective Autophagy to Alleviate Atherosclerosis.
Cheng Y; Pan X; Wang J; Li X; Yang S; Yin R; Ma A; Zhu X
Oxid Med Cell Longev; 2020; 2020():3186306. PubMed ID: 33505579
[TBL] [Abstract][Full Text] [Related]
20. Xinmaikang (XMK) tablets alleviate atherosclerosis by regulating the SREBP2-mediated NLRP3/ASC/Caspase-1 signaling pathway.
Hou C; Jiang X; Sheng W; Zhang Y; Lin Q; Hong S; Zhao J; Wang T; Ye X
J Ethnopharmacol; 2024 Jan; 319(Pt 2):117240. PubMed ID: 37777030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
